Literature DB >> 32476912

High mobility group box 1 protein in bronchoalveolar lavage fluid and correlation with other inflammatory markers in pulmonary diseases.

Magda Suchankova1, Vladimira Durmanova1, Elena Tibenska2, Eva Tedlova3, Ivan Majer3, Helena Novosadova3, Juraj Demian3, Miroslav Tedla4, Maria Bucova1.   

Abstract

Objectives: Analysis of new markers in bronchoalveolar lavage fluid (BALF) provides new insights into the immunopathogenesis and may be helpful in differential diagnosis of lung diseases. High mobility group box 1 protein (HMGB1) is a non-histone nuclear protein and its release into the extracellular environment may be associated with the inflammatory response. The aim of the study is the analysis of HMGB1 in BALF, correlations with other markers of inflammation and differences in extracellular HMGB1 levels in various lung diagnoses.
Methods: The concentration of HMGB1 was tested by an Elisa test. We calculated correlations with other inflammatory markers (leukocytes, total protein, albumin, IgG, IgA, IgM, C3 complement component, alpha-2macroglobuline, CD3, CD4, CD8, TREM-1 and TREM-2) and specified HMGB1 level in various diagnoses.
Results: A positive correlation was found between the level of HMGB1 and total protein levels (p=0.0001), albumin (p=0.0058), IgA (p=0.011), IgM (0.0439) and TREM-2 (p=0.0188). Conversely, a negative correlation was revealed between HMGB1 and TREM-1 (p=0.0009). HMGB1 level varied in different diagnoses: the highest level was detected in QuantiFERON TB-positive subjects (median: 30.2) and hypersensitivity pneumonitis (median: 33.2), followed by pulmonary sarcoidosis (median: 16.8) and idiopathic pulmonary fibrosis (median: 8.8).
Conclusion: HMGB1 correlates with other inflammatory markers tested in BALF. Its level varies in different lung diagnoses. (Sarcoidosis Vasc Diffuse Lung Dis 2018; 35: 268-275). Copyright:
© 2018.

Entities:  

Keywords:  DPLD; hypersensitivity pneumonitis; sarcoidosis; tuberculosis

Year:  2018        PMID: 32476912      PMCID: PMC7170153          DOI: 10.36141/svdld.v35i3.5726

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  31 in total

1.  Elevated HMGB1-related interleukin-6 is associated with dynamic responses of monocytes in patients with active pulmonary tuberculosis.

Authors:  Jin-Cheng Zeng; Wen-Yu Xiang; Dong-Zi Lin; Jun-Ai Zhang; Gan-Bin Liu; Bin Kong; Yu-Chi Gao; Yuan-Bin Lu; Xian-Jing Wu; Lai-Long Yi; Ji-Xin Zhong; Jun-Fa Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Differential expression of IL-33 and HMGB1 in the lungs of stable cystic fibrosis patients.

Authors:  Kerstin Tiringer; Angela Treis; Stefan Kanolzer; Carina Witt; Bahil Ghanim; Saskia Gruber; Klara Schmidthaler; Sabine Renner; Eleonora Dehlink; Edith Nachbaur; Thomas Frischer; Walter Klepetko; Cezmi A Akdis; Zsolt Szépfalusi; Thomas Eiwegger
Journal:  Eur Respir J       Date:  2014-06-25       Impact factor: 16.671

3.  A new group of chromatin-associated proteins with a high content of acidic and basic amino acids.

Authors:  G H Goodwin; C Sanders; E W Johns
Journal:  Eur J Biochem       Date:  1973-09-21

4.  Changed phagocytic activity and pattern of Fcγ and complement receptors on blood monocytes in sarcoidosis.

Authors:  Anna Dubaniewicz; Marlena Typiak; Monika Wybieralska; Marta Szadurska; Szymon Nowakowski; Agnieszka Staniewicz-Panasik; Katarzyna Rogoza; Adam Sternau; Peter Deeg; Piotr Trzonkowski
Journal:  Hum Immunol       Date:  2012-05-15       Impact factor: 2.850

Review 5.  Tolerance, danger, and the extended family.

Authors:  P Matzinger
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

Review 6.  Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

7.  Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein.

Authors:  Jong Sung Park; Daiva Svetkauskaite; Qianbin He; Jae-Yeol Kim; Derek Strassheim; Akitoshi Ishizaka; Edward Abraham
Journal:  J Biol Chem       Date:  2003-12-04       Impact factor: 5.157

8.  Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin.

Authors:  Rabab El Mezayen; Mohamed El Gazzar; Michael C Seeds; Charles E McCall; Stephen C Dreskin; Mark R Nicolls
Journal:  Immunol Lett       Date:  2007-05-25       Impact factor: 3.685

9.  Macrophage polarization in interstitial lung diseases.

Authors:  Paweł Wojtan; Michał Mierzejewski; Iwona Osińska; Joanna Domagała-Kulawik
Journal:  Cent Eur J Immunol       Date:  2016-07-15       Impact factor: 2.085

10.  TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria.

Authors:  Elsa-Noah N'Diaye; Catherine S Branda; Steven S Branda; Lisette Nevarez; Marco Colonna; Clifford Lowell; Jessica A Hamerman; William E Seaman
Journal:  J Cell Biol       Date:  2009-01-26       Impact factor: 10.539

View more
  1 in total

Review 1.  Innate and Adaptive Immunity in Noninfectious Granulomatous Lung Disease.

Authors:  Amy S McKee; Shaikh M Atif; Michael T Falta; Andrew P Fontenot
Journal:  J Immunol       Date:  2022-04-15       Impact factor: 5.426

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.